| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biomarin Pharmaceutical Inc. (BMRN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. BMRN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 159.4K | $8.91M | - | |
| VP | 80.0K | $4.47M | - | |
| VP | 55.1K | $3.08M | - | |
| Dir | 49.4K | $2.76M | - | |
| Dir | 46.4K | $2.60M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 24, 2020 | Fuchs Henry J | President, Worldwide R&D | Sell | 20,000 | $95.88 | $1,917,617.48 | -5.9% | |
| Apr 20, 2020 | Fuchs Henry J | President, Worldwide R&D | Sell | 17,213 | $90.00 | $1,549,170.00 | -12.3% | |
| Apr 9, 2020 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 10,000 | $79.06 | $790,600.00 | -3.2% | |
| Apr 8, 2020 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 2,407 | $79.98 | $192,511.86 | -3.7% | |
| Apr 1, 2020 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 1,537 | $82.00 | $126,034.00 | -2.3% | |
| Mar 25, 2020 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 3,659 | $76.18 | $278,733.22 | -2.6% | |
| Mar 17, 2020 | Lawlis V Bryan53 | Director | Sale+OE | 8,360 | $76.01 | $635,469.70 | -18.0% | |
| Mar 9, 2020 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 10,000 | $89.52 | $895,200.00 | -3.3% | |
| Feb 3, 2020 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 10,000 | $83.50 | $835,000.00 | -3.0% | |
| Jan 14, 2020 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 8,000 | $87.95 | $703,600.00 | -2.4% |